Kala Pharmaceuticals, Inc. (KALA)

USD 3.38

(-1.15%)

Operating Expenses Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual operating expenses in 2023 was 39.15 Million USD , down -53.02% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly operating expenses in 2024 Q1 was 11.7 Million USD , up 26.28% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported a annual operating expenses of 82.68 Million USD in annual operating expenses 2022, down -29.07% from previous year.
  • Kala Pharmaceuticals, Inc. reported a annual operating expenses of 116.57 Million USD in annual operating expenses 2021, up 17.26% from previous year.
  • Kala Pharmaceuticals, Inc. reported a quarterly operating expenses of 11.7 Million USD for 2024 Q1, up 26.28% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported a quarterly operating expenses of 9.27 Million USD for 2023 Q4, down -11.76% from previous quarter.

Annual Operating Expenses Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Operating Expenses of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 39.15 Million USD -53.02%
2022 82.68 Million USD -29.07%
2021 116.57 Million USD 17.26%
2020 99.42 Million USD 7.73%
2019 92.29 Million USD 42.6%
2018 64.72 Million USD 62.31%
2017 39.87 Million USD 22.06%
2016 32.66 Million USD 104.3%
2015 15.99 Million USD 0.0%

Peer Operating Expenses Comparison of Kala Pharmaceuticals, Inc.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD -374.417%
Alpha Teknova, Inc. 45.85 Million USD 14.623%
ANI Pharmaceuticals, Inc. 195.98 Million USD 80.022%
Aquestive Therapeutics, Inc. 44.85 Million USD 12.71%
Collegium Pharmaceutical, Inc. 159.2 Million USD 75.408%
Cosmos Health Inc. 26.18 Million USD -49.549%
Journey Medical Corporation 54.59 Million USD 28.283%
Embecta Corp. 528.4 Million USD 92.59%
Esperion Therapeutics, Inc. 271.89 Million USD 85.6%
Dynavax Technologies Corporation 219.14 Million USD 82.134%
Intra-Cellular Therapies, Inc. 590 Million USD 93.364%
Pacira BioSciences, Inc. 326.37 Million USD 88.004%
PainReform Ltd. 9.58 Million USD -308.525%
Sunshine Biopharma, Inc. 13.12 Million USD -198.321%
Sunshine Biopharma, Inc. 13.12 Million USD -198.321%
SCYNEXIS, Inc. 51.84 Million USD 24.485%
Safety Shot Inc 12.1 Million USD -223.319%
China SXT Pharmaceuticals, Inc. 3.06 Million USD -1175.679%
Procaps Group, S.A. 199.47 Million USD 80.372%
Theratechnologies Inc. 72.75 Million USD 46.186%
Harrow Health, Inc. 89.97 Million USD 56.484%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD -314.493%
Biofrontera Inc. 39.95 Million USD 2.017%
DURECT Corporation 43.71 Million USD 10.436%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 92.599%
Cronos Group Inc. 96.7 Million USD 59.515%
OptiNose, Inc. 85.1 Million USD 53.993%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 83.133%
RedHill Biopharma Ltd. -9.56 Million USD 509.507%
Organogenesis Holdings Inc. 314.13 Million USD 87.536%
Guardion Health Sciences, Inc. 9.73 Million USD -302.36%
Cumberland Pharmaceuticals Inc. 43.04 Million USD 9.032%
Radius Health, Inc. 265.92 Million USD 85.277%
Universe Pharmaceuticals INC 13.84 Million USD -182.858%
ProPhase Labs, Inc. 37.85 Million USD -3.437%
Phibro Animal Health Corporation 260.29 Million USD 84.958%
Procaps Group S.A. 187.24 Million USD 79.09%
Alvotech 285.43 Million USD 86.283%
TherapeuticsMD, Inc. 9.82 Million USD -298.504%
Viatris Inc. 5.96 Billion USD 99.344%
Rockwell Medical, Inc. 15.37 Million USD -154.67%
Aytu BioPharma, Inc. 59.84 Million USD 34.571%
SIGA Technologies, Inc. 22.04 Million USD -77.621%
Tilray Brands, Inc. 251.35 Million USD 84.423%
Lifecore Biomedical, Inc. 49.03 Million USD 20.158%
Shineco, Inc. 17.94 Million USD -118.146%
PetIQ, Inc. 192.72 Million USD 79.685%
Regencell Bioscience Holdings Limited 3.99 Million USD -880.998%
Incannex Healthcare Limited 30.05 Million USD -30.28%
Neurocrine Biosciences, Inc. 1.59 Billion USD 97.548%
Alimera Sciences, Inc. 62.64 Million USD 37.496%
Silver Spike Investment Corp. 762.49 Thousand USD -5034.874%
Assertio Holdings, Inc. 368.58 Million USD 89.377%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD -565.237%
Petros Pharmaceuticals, Inc. 17.8 Million USD -119.855%
Clever Leaves Holdings Inc. 21.16 Million USD -84.954%
Cyclo Therapeutics, Inc. 21.04 Million USD -86.07%
Avadel Pharmaceuticals plc 164.96 Million USD 76.266%
Hempacco Co., Inc. 7.59 Million USD -415.412%
Talphera, Inc. 11.99 Million USD -226.438%
Alvotech 285.43 Million USD 86.283%
Eagle Pharmaceuticals, Inc. 140.71 Million USD 72.175%
Lantheus Holdings, Inc. 344.9 Million USD 88.648%
Currenc Group, Inc. 24 Million USD -63.123%
Kamada Ltd. 45.42 Million USD 13.809%
Indivior PLC 911 Million USD 95.702%
Evoke Pharma, Inc. 12.4 Million USD -215.505%
Flora Growth Corp. 10.57 Million USD -270.101%
Cyclo Therapeutics, Inc. 21.04 Million USD -86.07%
Evolus, Inc. 189.75 Million USD 79.367%
HUTCHMED (China) Limited 436.23 Million USD 91.025%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 74.598%
Akanda Corp. 3.48 Million USD -1023.953%